4536 Santen Pharmaceutical
- May 18, 2025
- 1 min read
Santen is the leader in ophthalmic pharmaceuticals, including treatments for glaucoma, age-related macular degeneration, and dry eye. Famous for the over-the-counter eye drop brand "Sante."
top of page
No.1 English-language social media platform for Japanese stocks
Powered by Japan Guru
1 Comment
bottom of page
"With one-third of the global population currently nearsighted and potentially half by 2050, demand for Santen’s drugs to slow myopia progression is expected to grow"
ーTrivista Capital @ Sohn Hong Kong Investment Leaders Conference, May 30, 2025